A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Maria BassanelliMarina BorroMichela RobertoDiana GiannarelliSilvana GiacintiSimona Di MartinoAnna CeribelliAndrea RussoAnnamaria AschelterStefania ScarpinoAndrea MontoriEdoardo PescarmonaSilverio TomaoMaurizio SimmacoFrancesco CognettiMichele MilellaMarina Chiara GarassinoPublished in: Cancers (2021)
The identified Genomic Signatures may serve as potential biomarkers for prognosis prediction of non-metastatic RCC and could drive both follow-up and treatment personalization in RCC management.